This statistic depicts the number of select types of cellular immunotherapies being developed globally in 2019, 2020, and 2021, including all phases from preclinical through approval and marketed products. Most of the therapies used chimeric antigen receptor T-cells (CAR-T).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Labiotech. (March 1, 2023). Number of cell therapies in development worldwide from 2019 to 2021, by strategy [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 23, 2026, from /statistics/1377198/cell-therapy-studies-globally-by-strategy/
Labiotech. "Number of cell therapies in development worldwide from 2019 to 2021, by strategy." Chart. March 1, 2023. ÌÇÐÄÆƽâ°æ. Accessed July 23, 2026. /statistics/1377198/cell-therapy-studies-globally-by-strategy/
Labiotech. (2023). Number of cell therapies in development worldwide from 2019 to 2021, by strategy. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 23, 2026. /statistics/1377198/cell-therapy-studies-globally-by-strategy/
Labiotech. "Number of Cell Therapies in Development Worldwide from 2019 to 2021, by Strategy." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 1 Mar 2023, /statistics/1377198/cell-therapy-studies-globally-by-strategy/
Labiotech, Number of cell therapies in development worldwide from 2019 to 2021, by strategy ÌÇÐÄÆƽâ°æ, /statistics/1377198/cell-therapy-studies-globally-by-strategy/ (last visited July 23, 2026)
Number of cell therapies in development worldwide from 2019 to 2021, by strategy [Graph], Labiotech, March 1, 2023. [Online]. Available: /statistics/1377198/cell-therapy-studies-globally-by-strategy/
